An improved Fc function assay utilizing CMV antigen-coated red blood cells generated with synthetic function-spacer-lipid constructs

Vox Sanguinis

Volumn 102, Issue 1, 2012, Pages 72-78

  Georgakopoulos, T ^a   Komarraju, S ^b   Henry, S ^b   Bertolini, J ^a  

^a Research and Development Department   (Australia)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

Fc function; Immunoglobulins; Kodecytes

Indexed keywords

CARBOHYDRATE; CARBOHYDRATE BINDING PROTEIN; COMPLEMENT; CYTOMEGALOVIRUS ANTIGEN PP65; EPITOPE; FC RECEPTOR; FUNCTION SPACER LIPID; IMMUNOGLOBULIN; LIPID; UNCLASSIFIED DRUG;

ACCURACY; ANTIGEN SPECIFICITY; ARTICLE; BIOENGINEERING; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS; CARBOHYDRATES; CYTOMEGALOVIRUS; EPITOPES; ERYTHROCYTES; EUROPE; HEMOLYSIS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; LIPIDS; PEPTIDES; SURFACE PROPERTIES; TEMPERATURE;

EID: 84655167648     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01512.x     Document Type: Article

References (21)

1. Schroeder HW, Wald D, Greenspan NS: Immunoglobulins: structure and function; in Paul WE (ed.): Fundamental Immunology. Philadelphia, Lippincott Williams & Wilkins, 2008:125-150.
2. B cell receptors, immunoglobulin and Fc receptors; in Klein J, Horejsi V (eds): Immunology. London, Blackwell Science, 1997:204-270.
3. Virella G: Biosynthesis, metabolism and biological properties of immunoglobulins; in Virella G (ed.): Medical Immunology. New York, Marcel Dekker, 2005:109-121.
4. Test for Fc function of immunoglobulin in European Pharmacopoeia (Monograph 2.7.9), Edition 6, Volume 1. Strasbourg, European Directorate for the Quality of Medicines & HealthCare, 2007.
5. Gronski P, Kanzy EJ, Seiler FR: Measurement of Fc function on human immunoglobulin preparations. Pharmeuropa 1991; 3:287-292.
6. Georgakopoulos T, Tatford OC, Tan CS, et al.: An improved method for the determination of Fc function of immunoglobulins. Vox Sang 2009; 96:133-137.
7. Gurevich V, Bertolini J, Lyons K: Determination of Fc function with frozen red blood cells. Biologicals 2006; 34:221-222.
8. Frame T, Carroll T, Korchagina E, et al.: Synthetic glycolipid modification of red blood cell membranes. Transfusion 2007; 47:876-882.
9. Henry S: Modification of red blood cells for laboratory quality control use. Curr Opin Hematol 2009; 16:467-472.
10. Harrison AL, Olsson ML, Jones RB, et al.: A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms. Glycoconj J 2010; 27:515-524.
11. Heathcote D, Carroll T, Wang J-J, et al.: Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells. Transfusion 2010; 50:635-641.
12. Galili U, Rachmilewitz EA, Peleg A, et al.: A unique natural human IgG antibody with anti-α-Galactosyl specificity. J Exp Med 1984; 160:1519-1531.
13. Macher BA, Galili U: The Galα1, 3Galb1, 4GlcNAc-R (α-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 2008; 1780:75-88.
14. Beers MH, Porter RS (eds): Merck Manual of Diagnosis and Therapy, 18th edn. New Jersey, Merck Research Laboratories, 2006.
15. 2 subclass. J Allergy Clin Immunol 2009; 123:1268-1276.
16. Novák J, Sova P, Krchnák V, et al.: Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides. J Gen Virol 1991; 72:1409-1413.
17. Ripalti A, Ruan Q, Boccuni MC, et al.: Construction of polyepitope fusion antigens of human cytomegalovirus ppUL32: reactivity with human antibodies. J Clin Microbiol 1994; 32:358-363.
18. Guidance for Industry - bioanalytical method validation.
19. Jorquera JI: Flebogamma 5% DIF development: rationale for a new option in intravenous immunoglobulin therapy. Clin Exp Immunol 2009; 157:17-21.
20. Vlug A, Nieuwenhuys EJ, van Eijk RV, et al.: Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin 1994; 52:561-567.
21. Hooper JA: Production and properties of intravenous immunoglobulins; in Lee ML, Strand V (eds): Intravenous Immunoglobulins in Clinical Practice. New York, Marcel Dekker, 1997:37-55.